<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Aquaporin-4 (AQP4) plays an important role in the evolution of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Experimental studies have also demonstrated anti-<z:hpo ids='HP_0000969'>edema</z:hpo> effects of arginine-vasopressin (AVP) <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>In a well-characterized murine model of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, we tested the hypotheses that treatment with selective AVP V(1) but not V(2) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (1) attenuates injury volume and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked <z:hpo ids='HP_0002181'>cerebral edema</z:hpo>; and (2) modulates <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked AQP4 expression </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:chebi fb="0" ids="6015">Isoflurane</z:chebi>-anesthetized adult male C57bl/6 mice were subjected to 60 min of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) by the intraluminal suture technique </plain></SENT>
<SENT sid="4" pm="."><plain>Adequacy of MCAO and reperfusion was monitored with laser-Doppler flowmetry over the ipsilateral parietal cortex </plain></SENT>
<SENT sid="5" pm="."><plain>Mice were treated with intracerebroventricular injection of selective AVP V(1) and V(2) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> or control vehicle (0.9% saline) </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume (tetrazolium staining), <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> (wet-to-dry ratios) and AQP4 protein expression (immunoblotting) were determined in different treatment groups in separate sets of experiments at 24 h of reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:mpath ids='MPATH_124'>Infarct</z:mpath> volume (percentage of contralateral structure; mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) was significantly attenuated in mice treated with 500 ng V(1) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> as well as at a dose of 1000 ng compared to controls </plain></SENT>
<SENT sid="8" pm="."><plain>However, there was no difference in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume following treatment with 1000 ng V(2) <z:chebi fb="68" ids="48706">antagonist</z:chebi> as compared to controls </plain></SENT>
<SENT sid="9" pm="."><plain>Water content in the ischemic hemisphere was significantly attenuated with V(1) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (1000 ng) but not with V(2) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> as compared to controls </plain></SENT>
<SENT sid="10" pm="."><plain>Treatment with AVP V(1) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (1000 ng) but not V(2) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, significantly upregulated AQP4 protein expression (% beta-actin) compared to saline-treated mice in ipsilateral (ischemic) cerebral cortex </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These data demonstrate that following experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> AVP V(1) receptor antagonism: (1) attenuates injury volume and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked <z:hpo ids='HP_0002181'>cerebral edema</z:hpo>; (2) modulates AQP4 expression; and (3) may serve as an important therapeutic target for neuroprotection and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> </plain></SENT>
</text></document>